Data demonstrates superiority of circular RNA vs linear mRNA
Drug Discovery World
MAY 15, 2024
In vivo proof-of-concept for Circio Holding’s differentiated circVec platform approach to gene therapy has been demonstrated in two posters at the American Society of Gene & Cell Therapy (ASGCT) 2024 annual meeting. In recent experiments, Circio has observed up to four months circVec durability in vivo.
Let's personalize your content